AgenDx Biosciences Overview
- Founded
- 2014
- Status
- Private
- Latest Deal Type
- Series A
- (Upcoming)
- Investors
- 4
AgenDx Biosciences General Information
Description
Developer of a molecular diagnostics platform designed to offer healthcare professionals a wide range of nucleic-acid based testing. The company's platform helps in the expansion of the commercial viability of screening, diagnosing, treatment planning and monitoring, thus enabling healthcare professionals to offer better treatment and diagnostics for their patients.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Diagnostic Equipment
Other Healthcare Technology Systems
Primary Office
- 1400 East Angela Boulevard
- Unit 126
- South Bend, IN 46617
- United States
AgenDx Biosciences Timeline
AgenDx Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | Upcoming | Generating Revenue | ||||
| 3. Seed Round | 30-Jul-2019 | 00000 | 00.000 | Completed | Generating Revenue | |
| 2. Seed Round | 23-Jan-2018 | $675K | $2.23M | Completed | Generating Revenue | |
| 1. Seed Round | 15-Jan-2016 | $1.56M | $1.56M | 00.000 | Completed | Generating Revenue |
AgenDx Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
AgenDx Biosciences Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a molecular diagnostics platform designed to offer healthcare professionals a wide range of nucleic-acid ba
Decision/Risk Analysis
South Bend, IN
00.000
000000 0
0000000
ng elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
0000000000000
San Diego, CA
00
As of 0000
00.000
0.00
0000-00-00
00000000000
00.000
00000000
uis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure do
0000000000000 00000000
Richmond Hill, Canada
00
As of 0000
0000
00000000
0000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAgenDx Biosciences Competitors (21)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mindera | Venture Capital-Backed | San Diego, CA | 00 | 00.000 | 00000000000 | 00.000 |
| 000000000 0000 000 | Corporation | Richmond Hill, Canada | 00 | 0000 | 00000000 | 0000 |
| 000000000 | Corporate Backed or Acquired | Cambridge, MA | 00 | 000 | 000000&0 | 000 |
| 000000 00000000000 | Venture Capital-Backed | Pleasanton, CA | 000000000000 | |||
| 0000000 | Private Equity-Backed | Irvine, CA | 000 | 00000 | 000000000 - | 00000 |
AgenDx Biosciences Executive Team (4)
AgenDx Biosciences Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Kevin Connors | AgenDx Biosciences | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
AgenDx Biosciences Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| University Of Notre Dame USA In England | University | Minority | 000 0000 | 000000 0 | |
| The Judd Leighton Foundation | Limited Partner | Minority | 000 0000 | 000000 0 | |
| Vitalize Venture Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Elevate Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |